Factors Favoring the Toxic Effects of Metformin in Subjects with Type 2 Diabetes in Two Referral Hospital in Douala, Cameroon
Antoine Vayaraï Manaoda, Azinwi Ngumsi Fuh, Jacques Yinyang, Jean Pierre Nda Mefo’o, Jean pierre Ngene, Gisele Etame Loe & Dieudonné Adiogo · Journal of Advances in Medical and Pharmaceutical Sciences · 2022
Introduction: The Metformin is a first line agent for the treatment of type 2 diabetes that can be used alone or in combination with sulfonylureas thiazolidinediones, incretin-based drugs, sodium/glucose cotransporter-2 inhibitors, or other hypoglycemic agents. Metformin is the m...
Open access
Research Article
10.9734/jamps/2022/v24i130281